Technical Analysis for LJPC - La Jolla Pharmaceutical Company

Grade Last Price % Change Price Change
grade F 6.3 0.80% 0.05
LJPC closed up 0.8 percent on Friday, January 18, 2019, on approximately normal volume. The stock exhibited some range contraction during this trading session as price made an NR7 -- narrowest range of the last seven sessions. The price action carved out a bullish hammer (or hammer-like) candlestick pattern. That may indicate an upside reversal. Look for price to trade above the high of the hammer for confirmation.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Strong Down Down Up
See historical LJPC trend table...

Date Alert Name Type % Chg
Jan 18 Hammer Candlestick Bullish 0.00%
Jan 18 Narrow Range Bar Range Contraction 0.00%
Jan 18 NR7 Range Contraction 0.00%
Jan 18 Doji - Bullish? Reversal 0.00%
Jan 18 Wide Bands Range Expansion 0.00%
Jan 17 MACD Bullish Signal Line Cross Bullish 0.80%
Jan 17 Wide Bands Range Expansion 0.80%
Jan 16 Narrow Range Bar Range Contraction -3.96%
Jan 16 NR7 Range Contraction -3.96%
Jan 16 Wide Bands Range Expansion -3.96%

Older signals for LJPC ...

Free Daily (Stock) Chart Reading

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:

Profile
La Jolla Pharmaceutical Company, a biopharmaceutical company, focuses on the discovery, development, and commercialization of therapeutics for chronic organ failure and cancer. The company's products include GCS-100, a Phase-1/2 clinical trial drug used for the treatment of chronic kidney disease. It also provides LJPC-501, a peptide agonist of the renin-angiotensin system, which is designed to help restore kidney function in patients with hepatorenal syndrome. In addition, the company is developing LJPC-101, a subcutaneous formulation of GCS-100; LJPC-201, an oral galectin-3 inhibitor; and LJPC-301, a monoclonal antibody designed to neutralize galectin-3. La Jolla Pharmaceutical Company was founded in 1989 and is headquartered in San Diego, California.
Is LJPC a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 0 bullish, 4 bearish and 1 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 41.36
52 Week Low 5.01
Average Volume 918,779
200-Day Moving Average 22.8559
50-Day Moving Average 11.8658
20-Day Moving Average 7.955
10-Day Moving Average 6.155
Average True Range 0.9648
ADX 38.08
+DI 16.1631
-DI 36.6753
Chandelier Exit (Long, 3 ATRs ) 9.3556
Chandelier Exit (Short, 3 ATRs ) 7.9044
Upper Bollinger Band 11.6506
Lower Bollinger Band 4.2594
Percent B (%b) 0.28
BandWidth 92.912634
MACD Line -1.7389
MACD Signal Line -1.8084
MACD Histogram 0.0695
Fundamentals Value
Market Cap 139.38 Million
Num Shares 22.1 Million
EPS -5.12
Price-to-Earnings (P/E) Ratio -1.23
Price-to-Sales 5475.91
Price-to-Book 5.28
PEG Ratio -0.48
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 6.95
Resistance 3 (R3) 6.88 6.61 6.84
Resistance 2 (R2) 6.61 6.44 6.64 6.80
Resistance 1 (R1) 6.45 6.34 6.52 6.52 6.77
Pivot Point 6.18 6.18 6.21 6.21 6.18
Support 1 (S1) 6.02 6.01 6.09 6.09 5.83
Support 2 (S2) 5.75 5.91 5.78 5.80
Support 3 (S3) 5.59 5.75 5.76
Support 4 (S4) 5.66